KLHDC7B as a novel diagnostic biomarker in urine exosomal mRNA promotes bladder urothelial carcinoma cell proliferation and migration, inhibits apoptosis
Molecular Carcinogenesis · 2024
DOI: 10.1002/mc.23652 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Carcinogenesis, 2024. Verfasst von Jiayin Hou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Technology, Peking University Health Science Center, Beijing, China. Hauptthemen laut MEDLINE: Carcinoma, Transitional Cell, Urinary Bladder Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Bladder cancer is a common kind of urinary system cancer, in which bladder urothelial carcinoma (BLCA) comprises approximately 90% of all bladder cancer types. In our previous study, we discovered KLHDC7B in urine exosomal messenger RNA (mRNA) as a prospective molecular marker for bladder cancer detection. To systematically study the role and mechanism of KLHDC7B in BLCA, we focused on the most common type of BLCA in this study. First, we used RNA sequencing to discover that KLHDC7B was considerably increased in BLCA patients' urine exosomes compared to healthy controls. Then, we validated this result in an independent cohort and identified it as an effective tool for diagnosing and distinguishing high‐grade and low‐grade BLCA. Finally, we studied the role and mechanism of KLHDC7B in BLCA at the cellular level, providing a functional basis for its expression as a novel laboratory diagnostic biomarker for BLCA exosomal mRNA, which has important theoretical and clinical significance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Medical Technology, Peking University Health Science Center, Beijing, China.
- Department of Clinical Laboratory, Peking University First Hospital, Beijing, China.
- Department of Urology, Peking University First Hospital and Institute of Urology, Beijing, China.
Zitieren
APA
Hou, J., Huang, H., Xie, J., Yu, W., Hao, H., & Li, H. (2024). KLHDC7B as a novel diagnostic biomarker in urine exosomal mRNA promotes bladder urothelial carcinoma cell proliferation and migration, inhibits apoptosis. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23652
Vancouver
Hou J, Huang H, Xie J, Yu W, Hao H, Li H. KLHDC7B as a novel diagnostic biomarker in urine exosomal mRNA promotes bladder urothelial carcinoma cell proliferation and migration, inhibits apoptosis. Molecular Carcinogenesis. 2024. doi:10.1002/mc.23652
BibTeX
@article{Hou2024,
author = {Hou, Jiayin and Huang, Haiming and Xie, Junyi and Yu, Wei and Hao, Han and Li, Haixia},
title = {KLHDC7B as a novel diagnostic biomarker in urine exosomal mRNA promotes bladder urothelial carcinoma cell proliferation and migration, inhibits apoptosis},
journal = {Molecular Carcinogenesis},
year = {2024},
doi = {10.1002/mc.23652}
}
EUVIMED